Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
See Latest ArticlesCXCL13 and CXCL12 in Central Nervous System Lymphoma Patients
Clinical Cancer Research, 09/29/09
Fischer L et al. – The results suggest a production of CXCL13 within the CNS of CNS lymphoma patients, which decreases with response to therapy. Thus, CXCL13 may represent a marker for further diagnostic and prognostic studies.
Related Articles
Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy
Annals of Oncology, 10/30/09
Relevance Score: 81%
When do we need central nervous system prophylaxis in patients with extranodal NK/T-cell lymphoma, nasal type
Annals of Oncology, 10/29/09
Relevance Score: 80%
Primary central nervous system lymphoma: an update
Current Opinion in Oncology, 10/12/09
Relevance Score: 80%
Primary central nervous system lymphoma
Current Opinion in Neurology, 11/11/09
Relevance Score: 79%
Treatment options for central nervous system lymphomas in immunocompetent patients
Expert Review of Neurotherapeutics, 10/23/09
Relevance Score: 79%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Prognostic value of immunohistochemical profile and response to high-dose methotrexate therapy in primary CNS lymphoma
Journal of Neuro-Oncology, 12/16/09
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade : The Lancet Neurology
The Lancet Neurology, 12/16/09
HLA-DRB1 allele heterogeneity influences multiple sclerosis severity as well as risk in Western Australia
Journal of Neuroimmunology, 12/16/09
Today in Neurologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Telomere biology in neuroblastoma: telomere binding proteins and alternative strengthening of telomeres
Journal of Pediatric Surgery, 12/16/09
Risks and benefits of ending of mass screening for neuroblastoma at 6 months of age in Japan
Journal of Pediatric Surgery, 12/16/09
Prognostic value of immunohistochemical profile and response to high-dose methotrexate therapy in primary CNS lymphoma
Journal of Neuro-Oncology, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor